The anti-tumorigenic effects not only shared mechanisms, inhibiting CRC-risk microbes and enhancing adiponectin secretion, but also increased some specific gut microbes and triggered different anti-inflammatory and anti-oncogenic pathways. Here, ADIPOQ is linked to colorectal carcinoma.